环磷酰胺处理雄性小鼠后不同时间生殖损伤及致病机制OA
Reproductive injury at different time points after cyclophosphamide treatment in male mice and exploration of the underlying pathogenic mechanisms
目的 环磷酰胺(CTX)给药构建少弱精症(OAS)模型,寻找最佳成模时间,为进一步研究OAS提供更为适用的实验模型,并基于网络药理学预测可能的致病靶点及实验验证.方法 选取SPF级6周龄ICR系雄性小鼠共48只,随机分为对照组和模型组,模型组腹腔注射40 mg/kg的环磷酰胺,对照组注射生理盐水,1次/d,连续5 d,环磷酰胺处理结束后继续饲养14、28、35、42 d,记录小鼠体重,通过眼眶静脉采血后处死,取睾丸称重并计算其生殖器官指数及精子数量.HE染色观察睾丸组织病理学变化,精子质量分析测定精子相关指标.ELISA检测血清生殖激素含量,比较得出CTX诱导OAS模型.基于网络药理学及分子对接技术对其疾病机制进行探讨,并筛选核心靶点及通路进行体内实验验证.结果 与对照组相比,环磷酰胺处理结束后14、28、35和42 d的模型组小鼠体重及睾丸指数差异无统计学意义;环磷酰胺处理结束后,观察14 d和28 d小鼠精子数量发现,与对照组相比,模型组数量显著减少;28 d时,模型组睾酮、LH、抑制素B水平低于对照组,差异有统计学意义(P均<0.05);35 d时,模型组睾酮、抑制素B(P<0.05)低于对照组,LH水平高于对照组,FSH差异无统计学意义;42 d时,模型组睾酮、LH(P<0.05)、抑制素B低于对照组,FSH高于对照组.网络药理学通过对核心基因GO富集分析发现,这些共同靶点EGFR、CYP19A1主要涉及到醛固酮、皮质醇及睾酮生物合成过程等相关生物过程;KEGG富集分析结果显示,这些靶点与代谢途径、类固醇激素生物合成、HIF-1信号通路等存在密切联系.结论 CTX40 mg/(kg·d)连续腹腔注射5 d,给药后第28 d是建立CTX诱导小鼠OAS模型的最佳模型时间;通过网络药理学、分子对接技术分析及体内实验显示CTX致小鼠少弱精子症可能与EGFR、CYP19A1等靶点及HIF-1信号通路有关.
Objective To establish an oligoasthenospermia(OAS)mouse model induced by cyclophosphamide(CTX),determine the optimal modeling time point,and provide a suitable experimental model for further OAS research.In addition,to predict potential pathogenic targets and mechanisms using network pharmacology and to validate them ex-perimentally in vivo.Methods Forty-eight specific pathogen-free(SPF)6-week-old male ICR mice were ran-domly divided into a control group and a model group.The model group received intraperitoneal injections of cyclophos-phamide(40 mg/kg),while the control group received normal saline,once daily for 5 consecutive days.After completion of CTX administration,mice were maintained for 14,28,35,and 42 days.Body weight was recorded,and mice were sacrificed after orbital venous blood collection.Testes were harvested and weighed to calculate the reproductive organ in-dex,and sperm counts were determined.Histopathological changes in testicular tissue were examined using hematoxylin-eosin(HE)staining,and sperm quality parameters were assessed.Serum reproductive hormone levels were measured by ELISA to evaluate the CTX-induced OAS model.Network pharmacology and molecular docking approaches were applied to explore the underlying pathogenic mechanisms,and key targets and signaling pathways were further validated in vivo.Results Compared with the control group,no significant differences were observed in body weight or testicular index at 14,28,35,or 42 days after completion of CTX treatment.However,sperm counts at 14 and 28 days were significantly reduced in the model group compared with controls.At 28 days,serum testosterone,luteinizing hormone(LH),and in-hibin B levels were significantly lower in the model group(P<0.05).At 35 days,testosterone and inhibin B levels were significantly decreased(P<0.05),LH levels were increased,and no significant difference was observed in follicle-stimulating hormone(FSH)levels.At 42 days,testosterone,LH(P<0.05),and inhibin B levels were lower,whereas FSH levels were higher than those in the control group.Gene Ontology(GO)enrichment analysis based on network phar-macology revealed that the core targets epidermal growth factor receptor(EGFR)and cytochrome P450 family 19 subfamily A member 1(CYP19A1)were mainly involved in biological processes related to aldosterone,cortisol,and testosterone bi-osynthesis.Kyoto Encyclopedia of Genes and Genomes(KEGG)enrichment analysis indicated that these targets were closely associated with metabolic pathways,steroid hormone biosynthesis,and the hypoxia-inducible factor-1(HIF-1)signaling pathway.Conclusion Intraperitoneal injection of cyclophosphamide at 40 mg/(kg·d)for 5 consecutive days,with evaluation at 28 days after treatment,represents the optimal time point for establishing a CTX-induced oli-goasthenospermia mouse model.Network pharmacology,molecular docking,and in vivo experiments suggest that CTX-induced oligoasthenospermia may be associated with targets such as EGFR and CYP19A1 and involvement of the HIF-1 signaling pathway.
李晓荣;姜波;胡欣悦;马晓晴;张文燕;杨嘉欣;徐仙;景万红
宁夏医科大学总医院生殖医学中心(宁夏银川 750004)宁夏回族自治区第五人民医院中医科(宁夏石嘴山 753099)宁夏医科大学总医院生殖医学中心(宁夏银川 750004)宁夏医科大学总医院生殖医学中心(宁夏银川 750004)宁夏医科大学总医院生殖医学中心(宁夏银川 750004)宁夏医科大学总医院生殖医学中心(宁夏银川 750004)宁夏医科大学总医院生殖医学中心(宁夏银川 750004)宁夏医科大学总医院生殖医学中心(宁夏银川 750004)
医药卫生
环磷酰胺少弱精症生殖损伤ICR小鼠网络药理学
cyclophosphamideoligoasthenospermiareproductive injuryicr micenetwork pharmacology
《广东医学》 2026 (6)
806-815,10
宁夏回族自治区重点研发计划项目(2021BEG03114)宁夏自然科学基金资助项目(2025AAC030283)大学生创新创业训练计划项目(校级)(X202410752110)
评论